First, compared to WHO II and WHO III gliomas, we found that WHO IV GBM patients had relatively higher TREM2 expression in the three databases (Figures 1A, B and Supplementary Figure 2A), demonstrating that high TREM2 expression was predictive of high malignancy of glioma. This evidence concerns the gene TREM2 and glioblastoma.